In other countries
The same active substances on other registers, the same brand first.
- Sandoz NaratriptanCanada · 2.5 MG · Tablet · Sandoz Canada IncorporatedSame substance
- Teva-NaratriptanCanada · 1 MG · Tablet · Teva Canada LimitedSame substance
- Teva-NaratriptanCanada · 2.5 MG · Tablet · Teva Canada LimitedSame substance
- NARAMIG 2,5 mg COMPRIMIDOS RECUBIERTOS CON PELICULASpain · 2,78 mg · comprimido recubierto con película · Glaxo S.A.Same substance
- Naratriptan Kern Pharma 2.5 MG Comprimidos Recubiertos con Pelicula EfgSpain · 2,5 mg · comprimido recubierto con película · Kern Pharma S.L.Same substance
- Naramig, filmomhulde tabletten 2,5 mgNetherlands · Filmomhulde tablet · GlaxoSmithKline B.V.Same substance
- Naratriptan CF 2,5 mg, filmomhulde tablettenNetherlands · Filmomhulde tablet · Centrafarm B.V.Same substance
- Naratriptan HCl 2,5 mg Teva, filmomhulde tablettenNetherlands · Filmomhulde tablet · Teva Nederland B.V.Same substance
- Naratriptan Film-Coated Tablets 2.5MGSingapore · 2.50mg · tablet, film coated · Medicell Pharmaceutical (S) Pte. LTD.Same substance
- NaratriptanUnited States · 1MG BASE, 2.5MG BASE · tablet · Apotex CorpSame substance
- AmergeUnited States · 1MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, 2.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · tablet · Glaxosmithkline LLCSame substance
Sources and licences
Compiled by Prognia from the public register below; the register’s text is the official one.
Anvisa published factual open-data CSV https://dados.anvisa.gov.br/dados/CONSULTAS/PRODUTOS/TA_CONSULTA_MEDICAMENTOS.CSV, HTTP version Mon, 12 Oct 2026 11:45:25 GMT; acquired 12 October 2026; original source states and timestamps retained.
Licence: Brazil federal factual open data, consolidated Decreto 8777/2016 article 4; attribution and third-party exceptions · Added 12 Oct 2026
Report an error or request removalCorrections from the holder or the register are welcome.
Prognia shows this product information for reference and learning. It is not treatment advice and can lag behind the official text. Always check the current product information and local protocols before prescribing.
At a glance
- Active substance
- Naratriptan
- Register
- Brazil (Anvisa)
- Status
- Authorised
- Status in the register
- Ativo
- Authorised
- 14 Sept 2026
- Registration
- 100431600
- Marketing authorisation holder
- Eurofarma Laboratorios S.A.
- Procedure
- Registered